MAXCYTE, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 291.1 GBX | -1.32% |
|
-9.88% | -17.42% |
| 04-02 | MaxCyte inks deal with Be Bio; Orcadian firms farmout | AN |
| 04-02 | MaxCyte, Inc. Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | CI |
Quotes 5-day view
Delayed Quote London S.E.| 26/04/2024 | 29/04/2024 | 30/04/2024 | 01/05/2024 | 02/05/2024 | |
|---|---|---|---|---|---|
| Last | 295 p | 295 p | 295 p | 295 p | 291.1 p |
| Volume | 5 668 | 12 076 | 14 881 | 3 294 | 1 244 |
| Change | 0.00% | 0.00% | 0.00% | 0.00% | -1.32% |
| Opening | 295.00 | 295.00 | 300.00 | 295.00 | 295 |
| High | 300.00 | 300.00 | 300.00 | 292.00 | 297.8 |
| Low | 290.00 | 290.00 | 291.10 | 290.00 | 290 |
Performance
| 1 day | -1.32% | ||
| 1 week | -9.88% | ||
| Current month | -15.01% | ||
| 1 month | -13.10% | ||
| 3 months | -27.22% | ||
| 6 months | +23.87% | ||
| Current year | -17.42% | ||
| 1 year | -24.39% | ||
| 3 years | -67.94% | ||
| 5 years | +55.25% |
Volumes
marketsDaily volume
1 244
Estimated daily volume
1 929
Avg. Volume 20 sessions
10 984
Daily volume ratio
0.18
Avg. Volume 20 sessions GBX
3 197 442.40
Avg. Volume 20 sessions USD
3 197 442.40
Record volume 1
2 407 309
Record volume 2
2 394 641
Record volume 3
2 163 822
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (GBX)
385 155 611
Capitalization (USD)
385 155 611
Net sales (USD)
41 288 000
Number of employees
143
Sales / Employee (USD)
288 727
Free-Float
94.02 %
Free-Float capitalization (GBX)
360 760 429
Free-Float capitalization (USD)
360 760 429
Average Daily Capital Traded
0.83%
Highs and lows
1 week
290.00
336.00
1 month
290.00350.00
Current year
290.00430.00
1 year
170.00430.00
3 years
170.001 235.00
5 years
95.001 235.00
10 years
75.001 235.00
Indicators
Moving average 5 days
295.00
Moving average 20 days
316.75
Moving average 50 days
333.24
Moving average 100 days
359.43
Price spread / (MMA5)
+1.34%
Price spread / (MMA20)
+8.81%
Price spread / (MMA50)
+14.48%
Price spread / (MMA100)
+23.47%
STIM
RSI 9 days
22.89
RSI 14 days
26.96
Sector Comparison - Other Advanced Medical Equipment & Technology
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -1.32% | -9.88% | -17.42% | -24.39% | 385M | ||
| +1.10% | -0.42% | +8.33% | +4.83% | 219B | ||
| +0.11% | -1.41% | +6.72% | +2.13% | 183B | ||
| +0.29% | -0.88% | +10.18% | +22.67% | 132B | ||
| +0.47% | -0.96% | +24.91% | +36.76% | 106B | ||
| -1.36% | -1.46% | -2.28% | -9.09% | 62.09B | ||
| -0.44% | -4.86% | +10.56% | -3.71% | 50.8B | ||
| +0.82% | +9.36% | +4.81% | -2.34% | 50.88B | ||
| +1.20% | +0.87% | -0.24% | +1.92% | 40.64B | ||
| +2.65% | -9.76% | +1.22% | -3.12% | 35.71B | ||
| +0.48% | +16.99% | +24.99% | -8.28% | 31.59B | ||
| +1.32% | +1.47% | -10.46% | -38.37% | 19.86B | ||
| +2.23% | +1.83% | -4.04% | +5.94% | 18.74B | ||
| +0.65% | -0.58% | +6.74% | -13.01% | 17.91B | ||
| +2.97% | +3.77% | +10.56% | -5.94% | 16.21B | ||
| +0.13% | -0.08% | -6.14% | -21.23% | 12.67B | ||
| Average | +0.65% | +0.23% | +4.28% | -3.45% | ||
| Weighted average by Cap. | +0.39% | -0.24% | +8.45% | +5.93% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
17bd84e138f1ef0f8c54.U7cLhsm-u4mGM9TBH2VlyMB2awdcfT34BIIsOzmPlY8.fsFAsILP077ZSbmWczITjI4QXlgOFgu2dekVeGnL_Lsb_0Lymorqx95ijQ
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 11:15:23 | 291.1 | 144 | 1,244 |
| 09:00:20 | 290 | 600 | 1,100 |
| 08:38:23 | 297.8 | 16 | 500 |
Monthly variations
Annual change
| 2024 | -16.31% | ||
| 2023 | -19.43% | ||
| 2022 | -42.05% | ||
| 2021 | +43.13% | ||
| 2020 | +322.00% | ||
| 2019 | -33.86% | ||
| 2018 | -21.58% | ||
| 2017 | +75.27% | ||
| 2016 | +79.74% |
- Stock Market
- Equities
- MXCT Stock
- Quotes MaxCyte, Inc.
